ArticleSleep & breathing = Schlaf & Atmung2025
Machine learning insights into obesity related genes XRCC4 and ARL6 in obstructive sleep apnea.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sleep-Related Breathing Disorders: A Comprehensive Review of Surgical Innovations and Evolving Technologies.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeObstructive sleep apnea (OSA) is highly prevalent among obese individuals, with a complex and bidirectional relationship wherein obesity not only serves as a primary risk factor for OSA but also exacerbates its severity. This interconnection may be influenced by a set of shared genes; however, the molecular mechanisms linking obesity and OSA remain poorly characterized. This study aims to explore the molecular signatures and mechanisms underlying obesity-related genes in OSA.
methodsWe analyzed gene expression data from the GSE135917 dataset (training dataset) to identify obesity-related differentially expressed genes (DEGs) in OSA patients. Functional enrichment analyses and machine learning approaches were employed to explore associated biological pathways and develop predictive models. The findings were subsequently validated in an independent dataset, GSE38792.
resultsA total of 25 significant DEGs were identified, with 13 genes upregulated and 12 downregulated in OSA patients. Functional enrichment analysis revealed associations with insulin resistance, lipid metabolism, and Toll-like receptor signaling. Machine learning models highlighted XRCC4 and ARL6 as potential diagnostic biomarkers, validated in the independent GSE38792 dataset. XRCC4's role in DNA repair may be compromised by obesity-related inflammation and oxidative stress, while ARL6 is implicated in adipocyte function and intracellular signaling.
conclusionOur findings contribute to the understanding of obesity-related genes in OSA, proposing XRCC4 and ARL6 as novel biomarkers. This study underscores the complexity of the interactions between obesity and OSA, paving the way for future research into their shared molecular pathways.
Indexed as
Identifiers
41082129What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.